Innovator U.S. Small Cap Power Buffer ETF - April (BATS: KAPR)

Latest News for Innovator U.S. Small Cap Power Buffer ETF - April (BATS:KAPR)

Innovator U.S. Small Cap Power Buffer ETF - April

Second quarter&nbsp;revenue is expected to reflect approximately&nbsp;20%&nbsp;year-on-year growth and sequential growth of&nbsp;8%, with Adjusted EBITDA Margin in an expected range of&nbsp;20%&nbsp;to&nbsp;21%, or up 200 to 300 basis points year-on-year and sequentially in both cases based on the mid-point of&nbsp;second quarter&nbsp;guidance.&quot;

News

Guidance

XPRO

Expro Group Expects Q2 Revenue To Reflect Approximately 20% Y/Y Growth And Sequential Growth Of 8%

SPGI

S&P Global Raises FY24 Revenue Outlook From 5.5% - 7.5% to 6.0% - 8.0%

By <a href="https://roboforex.com/?utm_source=benzinga.com&amp;utm_medium=pr&amp;utm_campaign=rf_en_external_article_25042024&amp;utm_content=analysis&amp;utm_term=forecast" style="color:#0563c1; text-decoration:underline">RoboForex</a> Analytical Department
The USD/JPY pair reached an all-time high on Thursday, touching the 155.50 level. This development comes as the Bank of Japan (BoJ) starts its two-day monetary policy meeting with widespread expectations that the interest rate will remain unchanged at zero. Investors are keenly watching for any aggressive signals from the BoJ, as further declines in the yen could prompt Tokyo to intervene in the currency market. However, any such intervention is expected to provide only a short-term respite for the yen.
The primary driver behind the yen&#39;s weakness remains the significant disparity in monetary policies between the Bank of Japan and the US Federal Reserve, particularly regarding interest rates. The current situation will likely persist if there is no shift in these policies.
Last week, BoJ Governor Kazuo Ueda indicated at the G-20 summit that the regulator might consider raising rates if the yen&#39;s weakness leads to a sustained increase in import prices. The BoJ is closely monitoring inflation trends, and should the consumer price index approach the 2% target, the bank may adopt a more decisive stance.
The yen has been on a consistent downward trajectory since 13 March this year, showing few signs of interruption.
USD/JPY technical analysis
<a href="https://www.benzinga.com/files/u117641/usdjpyh4_12.png"><img alt="" src="https://www.benzinga.com/files/u117641/usdjpyh4_12.png" style="height:716px; width:1596px" /></a>
On the H4 chart, USD/JPY found support at 153.65, and the fifth wave of growth is unfolding. The pair is expected to reach 155.85 soon. Following this, a corrective move to at least 154.60 (testing from above) is anticipated, potentially followed by further growth towards 156.56. This target represents the primary objective of the growth wave. This bullish scenario is technically supported by the MACD oscillator, whose signal line is above zero and trending upwards.
<a href="https://www.benzinga.com/files/u117641/usdjpyh1_10.png"><img alt="" src="https://www.benzinga.com/files/u117641/usdjpyh1_10.png" style="height:716px; width:1596px" /></a>
On the H1 chart, USD/JPY has established support at 154.55, with the upward structure aiming for 155.85. Currently, the growth to 155.73 has been executed. A slight retracement to 155.20 (testing from above) may occur next. After reaching this level, the likelihood of an ascent to 155.85 will be reassessed. This technical outlook is confirmed by the Stochastic oscillator, whose signal line is currently above 80, poised for a drop to around 50.
Disclaimer
Any forecasts contained herein are based on the author&#39;s particular opinion. This analysis may not be treated as trading advice. RoboForex bears no responsibility for trading results based on trading recommendations and reviews contained herein.
This article is from an unpaid external contributor. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Japanese yen hits all-time low as BoJ meeting commences

Expro Group Reaffirms 2024 Guidance Of $1.6B-$1.7B Of Revenue (Est $1.652B) And $325M-$375M Of Adjusted EBITDA

Detroit-based automaker General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) on Tuesday detailed its plans for the relaunch of its autonomous driving unit Cruise, months after it paused operations owing to the involvement of one of its robotaxis in an <a href="https://www.benzinga.com/news/23/10/35052444/self-driving-cruise-car-accident-leaves-pedestrian-trapped-and-injured-in-san-francisco">accident in San Francisco</a>. 
What Happened: &#8220;We&#8217;re very excited that they&#8217;re back on the roads in Phoenix,&#8221; GM CEO Mary Barra said during the company&#8217;s first-quarter earnings call on Tuesday. Cruise is currently actively working to build regulator and customer trust, she noted. 
The company has strengthened the safety of its self-driving system and intends to demonstrate that the model works in one city before expanding to the next. Cruise accrued expenses of $400 million in the first quarter as compared to the $800 million in the quarter before. The company expects the unit&#8217;s <a href="https://www.benzinga.com/news/24/01/36862459/told-them-so-elon-musk-mocks-big-ticket-investor-who-chose-cruise-over-tesla-after-gms-self-driving">full-year expenses </a>to be around $1.7 billion. 
The company is presently exploring a few options to fund Cruise, including outside investment, Barra said. 
Why It Matters: Cruise suspended both autonomous and manual AV operations in the United States in October 2023. Earlier this month, the company <a href="https://www.benzinga.com/news/24/04/38155753/cruise-back-on-phoenix-roads-soon-gms-self-driving-unit-reportedly-gears-up-to-resume-robotaxi-testi">resumed manual driving in the city of Phoenix</a> to gather road information. 
These vehicles, Cruise then said, will be driven by humans without autonomous systems engaged. The company is looking to gradually scale up to driverless operations yet again. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a target="_blank" href="https://www.benzinga.com/topic/mobility" rel="noreferrer noopener">following this link</a>.
Read More: <a href="https://www.benzinga.com/news/24/04/38423295/ford-cfo-says-ev-price-cuts-bringing-down-revenue-faster-than-company-can-cut-costs-if-the-pricing-s">Ford CFO Says EV Price Cuts Bringing Down Revenue Faster Than Company Can Cut Costs; &#8216;If The Pricing Stabilizes&#8230;&#8217;</a>
Image Via Shutterstock

Tech

GM Unveils Plans For Autonomous Driving Unit Cruise Relaunch After Hiatus, Expects $1.7B In Expenses

WIIM

Southwest Airlines shares are trading lower after the company reported worse-than-expected Q1 financial results.

Earnings

Health Care

General

Laboratory Corporation Of America Holdings

Labcorp Expects 2024 Adjusted EPS Of $14.45-$15.35 Versus Prior Guidance Of $14.30-$15.40 And Consensus Of $14.82

First Foundation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FFWM#NYSE">FFWM</a>) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $0.01 by 100 percent. This is a 86.67 percent decrease over earnings of $0.15 per share from the same period last year. The company reported quarterly sales of $51.069 million which missed the analyst consensus estimate of $56.690 million by 9.92 percent. This is a 27.51 percent decrease over sales of $70.453 million the same period last year.

Earnings Beats

Earnings Misses

FFWM

First Foundation Q1 2024 Adj EPS $0.02 Beats $0.01 Estimate, Sales $51.069M Miss $56.690M Estimate

Baird analyst Tristan Gerra maintains Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) with a Neutral and raises the price target from $125 to $175.

Price Target

Analyst Ratings

Baird Maintains Neutral on Texas Instruments, Raises Price Target to $175

2%&nbsp;to&nbsp;4%&nbsp;(1%&nbsp;to&nbsp;3%&nbsp;on an organic basis).

For FY24, Dover Updated Adj. EPS Outlook To $9.00-$9.15 (From $8.95-$9.15 Prior) Vs. Consensus Of $9.06; Reaffirms Revenue Growth Of 2%-4% And 1%-3% On An Organic Basis

S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) reported quarterly earnings of $4.01 per share which beat the analyst consensus estimate of $3.66 by 9.56 percent. This is a 27.3 percent increase over earnings of $3.15 per share from the same period last year. The company reported quarterly sales of $3.49 billion which beat the analyst consensus estimate of $3.42 billion by 2.08 percent. This is a 10.47 percent increase over sales of $3.16 billion the same period last year.

S&P Global Q1 Adj $4.01 Beats $3.66 Estimate, Sales $3.49B Beat $3.42B Estimate

Dividends

NDAQ

Nasdaq Increases Quarterly Dividend From $0.22 To $0.24

Laboratory Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>) reported quarterly earnings of $3.68 per share which beat the analyst consensus estimate of $3.48 by 5.75 percent. This is a 6.36 percent increase over earnings of $3.46 per share from the same period last year. The company reported quarterly sales of $3.177 billion which beat the analyst consensus estimate of $3.117 billion by 1.93 percent. This is a 4.58 percent increase over sales of $3.038 billion the same period last year.

Laboratory Corp Q1 2024 Adj EPS $3.68 Beats $3.48 Estimate, Sales $3.177B Beat $3.117B Estimate

Ultralife (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULBI#NASDAQ">ULBI</a>) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.10 by 110 percent. The company reported quarterly sales of $41.927 million which beat the analyst consensus estimate of $38.000 million by 10.33 percent. This is a 31.37 percent increase over sales of $31.916 million the same period last year.

ULBI

Ultralife Q1 2024 Adj EPS $0.21 Beats $0.10 Estimate, Sales $41.927M Beat $38.000M Estimate

Biotech

Large Cap

Bristol Myers Squibb Revises 2024 Adjusted EPS Guidance From $7.10-$7.40 To $0.40-$0.70 Versus Consensus Of $0.66, Reflecting The Impact Of Recent Transactions

Baird analyst Mark Marcon maintains ASGN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) with a Neutral and raises the price target from $99 to $104.

ASGN

Baird Maintains Neutral on ASGN, Raises Price Target to $104

DTE Energy Reaffirms FY24 Operating EPS Of $6.54-$6.83 Vs. $6.69 Est.

Newmont Sees FY24 Attributable Gold Production Of 6,930Koz

LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 20 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $4.98 million which missed the analyst consensus estimate of $13.51 million by 63.15 percent. This is a 35.87 percent decrease over sales of $7.76 million the same period last year.

LVWR

LiveWire Gr Q1 EPS $(0.12) Beats $(0.14) Estimate, Sales $4.98M Miss $13.51M Estimate

Keurig Dr Pepper Reaffirmed FY24 Guidance For Constant Currency Net Sales Growth In Mid-Single-Digit Range And Adjusted Diluted EPS Growth In High-Single-Digit Range